NCT03421704View on ClinicalTrials.gov

A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV.

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Central Sleep ApneaMixed Sleep ApneaCheyne-Stokes RespirationComplex Sleep Apnea
Interventions
DEVICE

DreamStation BiPAP autoSV

Philips Respironics DreamStation BiPAP autoSV (PR DS-autoSV) is designed to deliver pressure support for patient ventilatory assistance

Trial Locations (9)

10117

Charité, Berlin

19049

Helios Kliniken Schwerin, Schwerin

42699

Wissenschaftliches Institut Bethanien für Pneumologie e.V, Solingen

93053

University Hospital Regensburg, Regensburg

6058091

Helios Klinik Hagen Ambrok, Hagen

Unknown

Universitätsklinikum der Ruhr-Universität Bochum, Bad Oeynhausen

Klinik Donaustauf, Donaustauf

Muenster University Hospital, Münster

Fachkrankenhaus Kloster, Schmallenberg

Sponsors
All Listed Sponsors
lead

Philips Respironics

INDUSTRY

NCT03421704 - A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV. | Biotech Hunter | Biotech Hunter